Isomorphic Labs Raises $5 Billion for AI Drug Discovery
Isomorphic Labs, the AI drug-discovery company co-founded by Demis Hassabis, has raised $5 billion in a new funding round, CNBC reported.
The financing highlights continued investor interest in applying artificial intelligence to drug discovery. It also comes several months after Hassabis left his role as CEO of Google DeepMind, although the report did not specify how his departure affects Isomorphic Labs' leadership or operations.